C38.3 Malignant neoplasm, mediastinum, part unspecified - analogs
| Description «C38.3 Malignant neoplasm, mediastinum, part unspecified» | ||||||
|
||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 30% Compare C38.1 Malignant neoplasm, anterior mediastinum
- 30% Compare C38.2 Malignant neoplasm, posterior mediastinum
- 23% Compare C78.1 Secondary malignant neoplasm of mediastinum
- 18% Compare C38.8 Malignant neoplasm, overlapping lesion of heart, mediastinum and pleura
- 18% Compare C38 Malignant neoplasm of heart, mediastinum and pleura
- 10% Compare C77 Secondary and unspecified malignant neoplasm of lymph nodes
- 10% Compare C34.1 Malignant neoplasm, upper lobe, bronchus or lung
- 10% Compare C34.9 Malignant neoplasm, bronchus or lung, unspecified
- 10% Compare C22.0 Malignant neoplasm, liver cell carcinoma
- 10% Compare E88.3 Tumour lysis syndrome
- 10% Compare C54.1 Malignant neoplasm, endometrium
- 10% Compare C93.0 Acute monoblastic/monocytic leukaemia
- 10% Compare C91.9 Lymphoid leukaemia, unspecified
- 10% Compare C67.9 Malignant neoplasm, bladder, unspecified
- 10% Compare C92.5 Acute myelomonocytic leukaemia
- 10% Compare C76-C80 Malignant neoplasms of inaccurately designated, secondary and unspecified localizations
- 10% Compare D29.0 Benign neoplasm, penis
- 10% Compare C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
- 10% Compare C67 Malignant neoplasm of bladder
- 10% Compare C22.9 Malignant neoplasm, liver, unspecified
- 10% Compare C51.9 Malignant neoplasm, vulva, unspecified
- 10% Compare D13.4 Benign neoplasm, liver
- 10% Compare C40.9 Malignant neoplasm, bone and articular cartilage of limb, unspecified
- 10% Compare C92.4 Acute promyelocytic leukaemia [PML]
- 10% Compare C94 Other leukaemias of specified cell type
- 10% Compare C15.5 Malignant neoplasm, lower third of oesophagus
- 10% Compare C32 Malignant neoplasm of larynx
- 10% Compare C40 Malignant neoplasm of bone and articular cartilage of limbs
- 10% Compare C91 Lymphoid leukaemia
- 10% Compare C22.7 Malignant neoplasm, other specified carcinomas of liver
- 10% Compare C94.2 Acute megakaryoblastic leukaemia
- 10% Compare C41.4 Malignant neoplasm, pelvic bones, sacrum and coccyx
- 10% Compare C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
- 10% Compare C30 Malignant neoplasm of nasal cavity and middle ear
- 10% Compare C40-C41 Malignant neoplasms of bones and articular cartilage
- 10% Compare C30.0 Malignant neoplasm, nasal cavity
- 10% Compare C15.4 Malignant neoplasm, middle third of oesophagus
- 10% Compare C71.0 Malignant neoplasm, cerebrum, except lobes and ventricles
- 10% Compare C41.0 Malignant neoplasm, bones of skull and face
- 10% Compare C49.4 Malignant neoplasm, connective and soft tissue of abdomen
- 10% Compare C15 Malignant neoplasm of oesophagus
- 10% Compare C70 Malignant neoplasm of meninges
- 10% Compare C18.3 Malignant neoplasm, hepatic flexure
- 10% Compare C74.9 Malignant neoplasm, adrenal gland, unspecified
- 10% Compare C95.0 Acute leukaemia of unspecified cell type
- 10% Compare C15.8 Malignant neoplasm, overlapping lesion of oesophagus
- 10% Compare C51 Malignant neoplasm of vulva
- 10% Compare C13.8 Malignant neoplasm, overlapping lesion of hypopharynx
- 10% Compare C77.3 Secondary and unspecified malignant neoplasm, axillary and upper limb lymph nodes
- 10% Compare C49.0 Malignant neoplasm, connective and soft tissue of head, face and neck
Learn more about the selection of analogues
- Medical online service designed to help in differential diagnostics.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.